Clinical trial
A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis…
NCT00408330 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00408330 |
|---|---|
| Title | A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face |
| Official title | A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face |
| Lead sponsor | LEO Pharma, Industry |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Seborrheic Dermatitis on the Face |
| Intervention type | Drug |
| Interventions | Azelaic Acid 15% Gel, Inactive 15% gel base |
| Enrollment | 48 |
| Start date | Dec 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Dec 6, 2006 |
| Last update posted | Jun 9, 2023 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: